PixCell Medical Expands HemoScreen Access Across Canada
Yokneam Illit, Israel, September 2, 2026 PixCell Medical has expanded its international presence into Canada through a strategic partnership...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Yokneam Illit, Israel, September 2, 2026 PixCell Medical has expanded its international presence into Canada through a strategic partnership...
Hamburg, Germany, and Sydney, Australia, September 2, 2026 Evotec SE and Plectonic Biotech have entered into a research collaboration...
Irvine, California, USA, September 1, 2026 SkinMedica, part of Allergan Aesthetics, an AbbVie company, has expanded its regenerative skincare...
